User profiles for "author:Deenan Pillay"
 | Deenan PillayVerified email at africacentre.ac.za Cited by 35904 |
[HTML][HTML] Digital technologies in the public-health response to COVID-19
Digital technologies are being harnessed to support the public-health response to COVID-
19 worldwide, including population surveillance, case identification, contact tracing and …
19 worldwide, including population surveillance, case identification, contact tracing and …
[HTML][HTML] 2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Günthard… - Topics in antiviral …, 2011 - ncbi.nlm.nih.gov
The development of more recently approved drugs that cannot be tested as monotherapy
precludes assessment of the impact of resistance on antiretroviral activity that is not …
precludes assessment of the impact of resistance on antiretroviral activity that is not …
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
MS Hirsch, HF Günthard, JM Schapiro… - Clinical Infectious …, 2008 - academic.oup.com
Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
[HTML][HTML] Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes… - PloS one, 2009 - journals.plos.org
Programs that monitor local, national, and regional levels of transmitted HIV-1 drug
resistance inform treatment guidelines and provide feedback on the success of HIV-1 …
resistance inform treatment guidelines and provide feedback on the success of HIV-1 …
[HTML][HTML] Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B. 1.1. 7 lineage in London, UK: a whole-genome sequencing and hospital-based …
D Frampton, T Rampling, A Cross, H Bailey… - The Lancet infectious …, 2021 - thelancet.com
Background Emergence of variants with specific mutations in key epitopes in the spike
protein of SARS-CoV-2 raises concerns pertinent to mass vaccination campaigns and use of …
protein of SARS-CoV-2 raises concerns pertinent to mass vaccination campaigns and use of …
[HTML][HTML] Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
A Banerjee, L Pasea, S Harris, A Gonzalez-Izquierdo… - The Lancet, 2020 - thelancet.com
Background The medical, societal, and economic impact of the coronavirus disease 2019
(COVID-19) pandemic has unknown effects on overall population mortality. Previous models …
(COVID-19) pandemic has unknown effects on overall population mortality. Previous models …
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn… - The Lancet infectious …, 2011 - thelancet.com
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …
[HTML][HTML] Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global …
Background The emergence and spread of high levels of HIV-1 drug resistance in resource-
limited settings where combination antiretroviral treatment has been scaled up could …
limited settings where combination antiretroviral treatment has been scaled up could …
[HTML][HTML] 2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard… - Topics in antiviral …, 2016 - ncbi.nlm.nih.gov
The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last
published in November 2015. The mutations listed are those that have been identified by …
published in November 2015. The mutations listed are those that have been identified by …
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
BG Gazzard, J Anderson, A Babiker… - HIV …, 2008 - pubmed.ncbi.nlm.nih.gov
British HIV Association Guidelines for the treatment of HIV-1-infected adults with
antiretroviral therapy 2008 British HIV Association Guidelines for the treatment of HIV-1-infected …
antiretroviral therapy 2008 British HIV Association Guidelines for the treatment of HIV-1-infected …